ProQR Therapeutics N.V.

Contributing Author

Recent Articles by ProQR Therapeutics N.V.

11 hours	ProQR Announces Year End 2025 Operating and Financial Results PRQR GlobeNewswire
Mar-03	ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference PRQR +13.33% PRQR -5.06% GlobeNewswire
Feb-09	ProQR Announces Planned Changes to Board Composition PRQR GlobeNewswire
Jan-08	ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook PRQR GlobeNewswire
Dec-01	ProQR to Participate in 8th Annual Evercore Healthcare Conference PRQR -9.40% GlobeNewswire
Nov-06	ProQR Announces Third Quarter 2025 Operating and Financial Results PRQR -7.14% GlobeNewswire
Oct-20	ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 PRQR +9.71% GlobeNewswire
Oct-13	ProQR to Participate in Upcoming Investor Conferences in October 2025 PRQR GlobeNewswire
Aug-07	ProQR Announces Second Quarter 2025 Operating and Financial Results PRQR GlobeNewswire
Jul-28	ProQR Announces Upcoming Presentation at RNA Editing Summit PRQR GlobeNewswire
Jun-26	ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP PRQR -5.56% PRQR GlobeNewswire
May-12	ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences PRQR GlobeNewswire
May-08	ProQR Announces First Quarter 2025 Operating and Financial Results PRQR GlobeNewswire
May-02	ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference PRQR +15.70% GlobeNewswire
May-01	ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 PRQR GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)